GSTM1 and anemia (phenotype): Roger et al. reported that CERA (1.2 μg/kg once every four weeks) successfully corrected anemia and maintained stable Hb levels within the recommended target range in non-dialysis CKD patients compared with DA (0.45 μg/kg once weekly or 0.75 μg/kg once every two weeks) [11].